Growth Metrics

Marchex (MCHX) EBIAT (2016 - 2025)

Marchex (MCHX) has disclosed EBIAT for 16 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • For Q4 2025, EBIAT fell 21.31% year-over-year to -$2.3 million; the TTM value through Dec 2025 reached -$5.2 million, down 5.82%, while the annual FY2025 figure was -$5.2 million, 5.82% down from the prior year.
  • EBIAT was -$2.3 million for Q4 2025 at Marchex, down from -$1.0 million in the prior quarter.
  • The five-year high for EBIAT was $3.3 million in Q3 2021, with the low at -$5.3 million in Q1 2021.
  • Historically, EBIAT has averaged -$1.6 million across 5 years, with a median of -$1.6 million in 2022.
  • The largest annual shift saw EBIAT surged 164.35% in 2021 before it plummeted 359.76% in 2022.
  • Over 5 years, EBIAT stood at -$2.0 million in 2021, then crashed by 75.63% to -$3.6 million in 2022, then skyrocketed by 68.02% to -$1.1 million in 2023, then plummeted by 67.1% to -$1.9 million in 2024, then dropped by 21.31% to -$2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were -$2.3 million in Q4 2025, -$1.0 million in Q3 2025, and $84000.0 in Q2 2025.